Cytotoxicity against human ARPE19 cells assessed as cell viability after 48 hrs by alamar blue assay
CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C,21600
CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)OC(=O)C)C)O)C,46500
CC(C)CCCC(C)C1CCC2C1(CCC3C2C(=O)C=C4C3(CCC(C4)O)C)C,32300
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(=O)C4(C3(CCC(C4)O)C)O)C,33900
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4)OC(=O)C)C)O)O)C,60000
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4)O)C)O)O)C,19100
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(=NO)C4(C3(CCC(C4)O)C)O)C,23700
CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C(C4C3(CCC(C4)O)C)O)O)C,19100
CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C(C4(C3(CCC(C4)O)C)O)OC(=O)C)OC(=O)C)C,11200
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4)O)C)O)OC)C,25800
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4)OC(=O)C)C)O)OC(=O)C)C,64100
CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C(C4(C3(CCC(C4)OC(=O)C)C)O)O)O)C,30500
CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4(C3(CCC(C4O)OC(=O)C)C)O)C,32500
CC(C)CCCC(C)C1CCC2C1(CCC3C2C(=O)C(C4(C3(CCC(C4)O)C)O)O)C,25700
CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C(C4(C3(CCC(C4)O)C)O)O)OC(=O)C)C,15800
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4)O)C)O)OC(=O)C)C,17900
CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C(C4(C3(CCC(C4)O)C)O)O)O)C,21400
CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4(C3(CCC(C4OC(=O)C)O)C)O)C,37400
CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4O)O)C)O)C,25600
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4)O)C)O)NC(=O)C)C,19000
CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C(C4(C3(CCC(C4)OC(=O)C)C)O)O)OC(=O)C)C,29000
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4O)O)C)O)O)C,20400
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4O)OC(=O)C)C)O)O)C,28800
